Clinical Research Centre
Hospital Tengku Ampuan Afzan
Kuantan, Pahang
WhoWe Are
The Clinical Research Centre Hospital Tengku Ampuan Afzan Kuantan (CRC HTAA) is one of the six research institutes under the National Institutes of Health (NIH) Ministry of Health Malaysia. Established in 2000, CRC has expanded to 33 branches at major hospitals in Malaysia. CRC HTAA was established in 2003, its aim is to cultivate a research culture among clinicians, compilation of information regarding all clinical research activities carried out in HTAA, and provide assistance to researchers. In the long term, CRC HTAA aims to ensure excellence and quality of clinical trials and establishing a centre of excellence in specific clinical area.
OurTeam
Project Highlights
Multicentre Clinical Epidemiological Study of Female Breast Cancer in a Multi-ethnic Malaysian Setting (Epi-Can)
NMRR ID-22-01338-NBF
Epi-Can is a multicentre retrospective cohort study that involves seven of the Ministry of Health (MOH) hospitals in Malaysia. This study aimed to determine the nature of breast cancer patients’ presentation, diagnosis, management of treatment, treatment-induced cardiovascular complications and survival while describing the variation across age, socioeconomic, geographic regions, ethnic differences and its trend over time in Malaysia. The results of this study will aid in observing secular changes as well as long-term outcomes for breast cancer patients in real-world clinical practice.
Contact: Shridevi Subramaniam
shridevi@crc.gov.my
Development and Validation of a Skin Mobile Application using Artificial Intelligence (A.I.) for Screening of Leprosy in Malaysian Population
NMRR ID-22-02743-GCO
Leprosy, a persistent infectious condition caused by Mycobacterium leprae, often remains hidden in our bodies for years, with an average incubation period of about 5 years and the potential to stay dormant for up to 20 years before revealing itself through visible symptoms.
Malaysia has achieved the remarkable status of leprosy elimination since 1994, boasting a prevalence rate of just 0.9 cases per 10,000 people. However, we still face challenges in detecting cases in a timely manner. Surprisingly, over 80% of our cases are the more severe multi-bacillary type of leprosy, and 5%-6% of new cases already exhibit permanent disabilities. Shockingly, more than 3% of these cases are children.
One significant hurdle to early detection is the low level of suspicion among our medical professionals. Awareness about leprosy and its telltale signs remains alarmingly inadequate. Often this disease is misdiagnosed as common skin ailments like contact dermatitis, psoriasis, eczema, vitiligo, or a simple skin infection.
With advances in deep learning and machine learning, particularly through convolutional neural networks (CNN), have revolutionized medical image analysis. In dermatology, these cutting-edge techniques have achieved astonishing accuracy rates of over 90% in diagnosing various skin conditions.
Our groundbreaking study aims to harness the power of AI-driven digital health screening using images to combat leprosy effectively, aligning with the WHO's global strategy to eliminate leprosy entirely, moving us closer to "Towards Zero Leprosy." This innovative concept expands access to timely patient care and accelerates treatment for those diagnosed positively, ensuring a brighter, healthier future for all.
Case-based Safety Monitoring of Adverse Events Following COVID-19 Vaccination (SAFECOVAC)
NMRR-21-822-59745
SAFECOVAC is an observational study of active safety surveillance for COVID-19 vaccines in Malaysia. The study team evaluates the risk of serious adverse events associated with the administration of COVID-19 vaccines among the vaccinated population. Findings from this study contributes to the local and global safety data of COVID-19 vaccines for recommendation on the COVID-19 immunisation programme.
Contact: Norazida Ab Rahman
norazida@moh.gov.my
List of Publications associated with CRC HTAA
- Diagnostic Yield of CT Pulmonary Angiogram in the Diagnosis of Pulmonary Embolism and Its Predictive Factors
- Chooi Leng Low, Ren Yi Kow, Azian Abd Aziz, Mubarak Mohd Yusof, Bee Chiu Lim, Norie Azilah Kamarudin, Ahmad Razali Md Ralib Md Raghib
- Real-World Treatment and Outcomes of ALK-Positive Metastatic Non-Small Cell Lung Cancer in a Southeast Asian Country
- Mau Ern Poh, Soon Hin How, Gwo Fuang Ho, Yong Kek Pang, Harissa H Hasbullah, Lye Mun Tho, Ibtisam Muhamad Nor, Bee Chiu Lim, Kean Fatt Ho, Muthukkumaran Thiagarajan, Azlina Samsudin, Azza Omar, Choo Khoon Ong, Sing Yang Soon, Justin Yu Kuan Tan, Muhammad Adil Zainal Abidin
Services at CRC Hospital Tengku Ampuan Afzan
CRC HTAA provides training through workshops and consultations:
-
Research Consultation Clinic (RCC)
-
Research registration: NMRR Service and Site Approval
Meet Our Collaborators
Upcoming Activities
Kindly visit CRC Pahang for further info on upcoming activities
CRC Hospital Tengku Ampuan Afzan, Kuantan, Pahang
Tingkat Bawah, Bangunan Pentadbiran
Jalan Tanah Putih
25100 Kuantan
Pahang Darul Makmur
Email: crchtaa@moh.gov.my | crchtaa@gmail.com
Phone number: +609 - 557 2478 / 2922 / 2923 | +6018 - 6302923